202
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Diacerein solid dispersion loaded tablets for minimization of drug adverse effects: statistical design, formulation, in vitro, and in vivo evaluation

ORCID Icon, &
Pages 302-315 | Received 06 Jul 2020, Accepted 24 Dec 2020, Published online: 11 Jan 2021

References

  • Aggarwal AK, Singh S. 2011. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000. Drug Dev Ind Pharm. 37(10):1181–1191.
  • Alcaraz MJ, Megías J, García-Arnandis I, Clérigues V, Guillén MI. 2010. New molecular targets for the treatment of osteoarthritis. Biochem Pharmacol. 80(1):13–21.
  • Allam AN, Hamdallah SI, Abdallah OY. 2017. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation. Int J Nanomedicine. 12:4733–4745.
  • Allen LV, Jr., Yanchick VA, Maness DD. 1977. Dissolution rates of corticosteroids utilizing sugar glass dispersions. J Pharm Sci. 66(4):494–497.
  • Aziz DE, Abdelbary AA, Elassasy AI. 2018. Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. Drug Deliv. 25(1):815–826.
  • Bennett RC, Brough C, Miller DA, O’Donnell KP, Keen JM, Hughey JR, Williams RO, McGinity JW. 2015. Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol dispersing: approaches to enhance solubility of a poorly water-soluble gum extract. Drug Dev Ind Pharm. 41(3):382–397.
  • Berenbaum F. 2010. Targeted therapies in osteoarthritis: a systematic review of the trials on www. Best Pract Res Clin Rheumatol. 24(1):107–119.
  • Bhirud YD, Phalak HM. 2016. Advances in solid dispersion technology and its applications in the development of solid dosage forms. J Drug Delivery Ther. 6(6):40–47.
  • Chen T, Fowler A, Toner M. 2000. Literature review: supplemented phase diagram of the trehalose–water binary mixture. Cryobiology. 40(3):277–282.
  • Chen Y, Zhang G, Neilly J, Marsh K, Mawhinney D, Sanzgiri YD. 2004. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int J Pharm. 286(1–2):69–80.
  • Cid AG, Simonazzi A, Palma SD, Bermúdez JM. 2019. Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs. Ther Deliv. 10(6):363–382.
  • Colombo M, de Lima Melchiades G, Michels LR, Figueiró F, Bassani VL, Teixeira HF, Koester LS. 2019. Solid dispersion of kaempferol: formulation development, characterization, and oral bioavailability assessment. AAPS PharmSciTech. 20(3):106.
  • de Oliveira Eloy J, Saraiva J, de Albuquerque S, Marchetti JM. 2012. Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity. AAPS PharmSciTech. 13(4):1436–1445.
  • Derringer G, Suich R. 1980. Simultaneous optimization of several response variables. J Qual Technol. 12(4):214–219.
  • El-Laithy HM, Basalious EB, El-Hoseiny BM, Adel MM. 2015. Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: simultaneous portal blood absorption and lymphatic delivery. Int J Pharm. 490(1–2):146–154.
  • Elsayed I, Abdelbary AA, Elshafeey AH. 2014. Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. Int J Nanomedicine. 9:2943–2953.
  • Eltobshi AA, Mohamed EA, Abdelghani GM, Nouh AT. 2018. Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein. Int J Nanomed. 13:6585–6602.
  • Fraile M, Martín ÿ, Deodato D, Rodriguez-Rojo S, Nogueira ID, Simplício AL, Cocero MJ, Duarte CMM. 2013. Production of new hybrid systems for drug delivery by PGSS (Particles from Gas Saturated Solutions) process. J Supercrit Fluids. 81:226–235.
  • Garthe OM, Kothawade PS, Mahajan VR. 2013. Solubility enhancement of diacerein by solid dispersion technique. Int J Pharma Res Allied Sci. 2(2):47–55.
  • Ghanem A, Meshali M, Ibraheem Y. 1980. Dissolution rates of sulfamethoxazole utilizing sugar glass dispersions. J Pharm Pharmacol. 32(10):675–677.
  • Hasan A, Abd El Hakim R, Mahmoud Abd E, Shereen S. 2020. Design and characterization of intra-oral fast dissolving tablets containing diacerein-solid dispersion. J Appl Pharma Sci. 10(06):44.
  • Jain A, Mishra SK, Vuddanda PR, Singh SK, Singh R, Singh S. 2014. Targeting of diacerein loaded lipid nanoparticles to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. Nanomed Nanotechnol Biol Med. 10(5):e1031–e1040.
  • Jain A, Singh R, Singh S, Singh S. 2015. Diacerein protects against iodoacetate-induced osteoarthritis in the femorotibial joints of rats. J Biomed Res. 29(5):405–413.
  • Jain A, Singh SK, Singh Y, Singh S. 2013. Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects. J Biomed Nanotechnol. 9(5):891–900.
  • Khan KA. 1975. The concept of dissolution efficiency. J Pharm Pharmacol. 27(1):48–49.
  • Khan MI, Madni A, Peltonen L. 2016. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur J Pharm Sci. 95:88–95.
  • Kolašinac N, Kachrimanis K, Homšek I, Grujić B, Ðurić Z, Ibrić S. 2012. Solubility enhancement of desloratadine by solid dispersion in poloxamers. Int J Pharm. 436(1–2):161–170.
  • Lana JFdSD, Rodrigues BL 2019. Osteoarthritis as a chronic inflammatory disease: a review of the inflammatory markers. London (UK): IntechOpen.
  • Li J, Li Y, Lee T, Huang Q. 2013. Structure and physical properties of zein/Pluronic F127 composite films. J Agric Food Chem. 61(6):1309–1318.
  • Lindner WD, Lippold BC. 1995. Drug release from hydrocolloid embeddings with high or low susceptibility to hydrodynamic stress. Pharm Res. 12(11):1781–1785.
  • Mohamed MI, Al-Mahallawi AM, Awadalla SM. 2020. Development and optimization of osmotically controlled drug delivery system for poorly aqueous soluble diacerein to improve its bioavailability. Drug Dev Ind Pharm. 46(5):814–825.
  • Mohamed MS, Abdelhafez WA, Zayed G, Samy AM. 2019. In vitro and in vivo characterization of fast dissolving tablets containing gliquidone–Pluronic solid dispersion. Drug Dev Ind Pharm. 45(12):1973–1981.
  • Mohammed KAB, Ibrahim HK, Ghorab MM. 2016. Effervescent tablet formulation for enhanced patient compliance and the therapeutic effect of risperidone. Drug Deliv. 23(1):297–306.
  • Nagasamy VD, Arun R, Saraswathi S, Priya MP, Khan NI, Kathirulla N, Sruthi S. 2017. Dissolution enhancement of diacerein using water soluble carrier by solid dispersion technology. J Drug Delivery Ther. 7(5):33–41.
  • Naima Z, Siro T, Juan-Manuel G, Chantal C, René C, Jerome D. 2001. Interactions between carbamazepine and polyethylene glycol (PEG) 6000: characterisations of the physical, solid dispersed and eutectic mixtures. Eur J Pharm Sci. 12(4):395–404.
  • Naseef MA, Ibrahim HK, Nour SAE. 2018. Solid form of lipid-based self-nanoemulsifying drug delivery systems for minimization of diacerein adverse effects: development and bioequivalence evaluation in albino rabbits. AAPS PharmSciTech. 19(7):3097–3109.
  • Ngo AN, Thomas D, Murowchick J, Ayon NJ, Jaiswal A, Youan BC. 2018. Engineering fast dissolving sodium acetate mediated crystalline solid dispersion of docetaxel. Int J Pharm. 545(1–2):329–341.
  • Panda T, Das D, Panigrahi L. 2016. Formulation development of solid dispersions of bosentan using Gelucire 50/13 and poloxamer 188. J Appl Pharm Sci. 6:27.
  • Parekh KK, Paun JS, Soniwala MM. 2017. Formulation and evaluation of nanosuspension to improve solubility and dissolution of diacerein. Int J Pharm Sci Res. 8(4):1643.
  • Passerini N, Perissutti B, Moneghini M, Voinovich D, Albertini B, Cavallari C, Rodriguez L. 2002. Characterization of carbamazepine–Gelucire 50/13 microparticles prepared by a spray‐congealing process using ultrasounds. J Pharm Sci. 91(3):699–707.
  • Patil SB, Shete DK, Narade SB, Surve SS, Khan ZK, Bhise SB, Pore YV. 2010. Improvement in the dissolution profile of diacerein using a surfactant-based solid dispersion technique. Drug Discov Ther. 4(6):435–441.
  • Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T. 2007. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm. 336(1):22–34.
  • Potluri RHK, Bandari S, Jukanti R, Veerareddy PR. 2011. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13. Arch Pharm Res. 34(1):51–57.
  • Radwan SAA, El-Maadawy WH, ElMeshad AN, Shoukri RA, Yousry C. 2020. Impact of reverse micelle loaded lipid nanocapsules on the delivery of gallic acid into activated hepatic stellate cells: a promising therapeutic approach for hepatic fibrosis. Pharm Res. 37(9):1–17.
  • Radwan SAA, El-Maadawy WH, Yousry C, ElMeshad AN, Shoukri RA. 2020. Zein/phospholipid composite nanoparticles for successful delivery of gallic acid into aHSCs: influence of size, surface charge, and vitamin A coupling. Int J Nanomedicine. 15:7995–8018.
  • Rockville MD, editor. 2012. United States Pharmacopeia and National Formulary (USP 35-NF 30). Rockville (MD): USP-NF. p. 5160–5174.
  • Saleh A, McGarry K, Chaw CS, Elkordy AA. 2018. Feasibility of using gluconolactone, trehalose and hydroxy-propyl gamma cyclodextrin to enhance bendroflumethiazide dissolution using lyophilisation and physical mixing techniques. Pharmaceutics. 10(1):22.
  • Sankari T, Al-Hariri S. 2018. Preparation and characterization of cefuroxime axetil solid dispersions using poloxamer 188. Braz J Pharm Sci. 54(4):e17644.
  • Sekiguchi K, Obi N. 1961. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull. 9(11):866–872.
  • Sostres C, Gargallo CJ, Arroyo MT, Lanas A. 2010. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 24(2):121–132.
  • Surampalli G, Nanjwade BK, Patil PA, Chilla R. 2016. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation. Drug Deliv. 23(7):2124–2138.
  • Suzuki H, Yakushiji K, Matsunaga S, Yamauchi Y, Seto Y, Sato H, Onoue S. 2018. Amorphous solid dispersion of meloxicam enhanced oral absorption in rats with impaired gastric motility. J Pharm Sci. 107(1):446–452.
  • Tran P, Pyo Y, Kim D, Lee S, Kim J, Park J. 2019. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 11(3):132.
  • Verhoeven N, Neoh TL, Furuta T, Yamamoto C, Ohashi T, Yoshii H. 2012. Characteristics of dehydration kinetics of dihydrate trehalose to its anhydrous form in ethanol by DSC. Food Chem. 132(4):1638–1643.
  • Vippagunta SR, Maul KA, Tallavajhala S, Grant DJ. 2002. Solid-state characterization of nifedipine solid dispersions. Int J Pharm. 236(1–2):111–123.
  • Volpato NM, Silva RL, Brito APP, Gonçalves JCS, Vaisman M, Noël F. 2004. Multiple level C in vitro/in vivo correlation of dissolution profiles of two l-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism. Eur J Pharm Sci. 21(5):655–660.
  • Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF, et al. 2017. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 390(10100):1211–1259.
  • Xi Z, Sharma N, Paprikar A, Lin S. 2019. Development and evaluation of dipyridamole sustained release tablets containing micro-environmental pH modifiers. J Drug Delivery Sci Technol. 54:101231.
  • Xu L, Faruqu FN, Liam-Or R, Abu Abed O, Li D, Venner K, Errington RJ, Summers H, Wang JT, Al-Jamal KT. 2020. Design of experiment (DoE)-driven in vitro and in vivo uptake studies of exosomes for pancreatic cancer delivery enabled by copper-free click chemistry-based labelling. J Extracell Vesicles. 9(1):1779458.
  • Zaki RM, Ali AA, El Menshawi SF, Bary AA. 2013. Effect of binary and ternary solid dispersions prepared by fusion method on the dissolution of poorly water soluble diacerein. Int J Drug Deliv. 5(1):99.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.